A[H1N1] flu and refractory hypoxaemia: is extracorporeal lung support the holy grail?

T V Veenith, M Rana, A Ercole, K Gunning, R Mahroof

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

There is a call for methodologically robust randomised clinical trials in adult extracorporeal membrane oxygenation for its routine implementation for patients with "failing" conventional ventilation. Adherence to lung protective ventilation strategies, along with fluid balance [if required early renal replacement therapy] and inotropes to support the circulation to minimise ventilator-induced lung injury, may mitigate deterioration requiring extracorporeal lung support. Currently there is no convincing evidence to routinely advocate extracorporeal lung support in failed conventional ventilation, and a prospective trial is needed to define standard best practice and to tailor extracorporeal lung support referral criteria in young patient cohort with severe refractory respiratory failure.

Original languageEnglish
Pages (from-to)836-7
Number of pages2
JournalThorax
Volume66
Issue number9
DOIs
Publication statusPublished - Sep 2011

Keywords

  • Adolescent
  • Adult
  • Extracorporeal Membrane Oxygenation/methods
  • Female
  • Follow-Up Studies
  • Humans
  • Hypoxia/complications
  • Influenza A Virus, H1N1 Subtype/isolation & purification
  • Influenza, Human/complications
  • Male
  • Middle Aged
  • Positive-Pressure Respiration/methods
  • Prospective Studies
  • Respiratory Insufficiency/etiology
  • Treatment Outcome
  • Young Adult

Fingerprint

Dive into the research topics of 'A[H1N1] flu and refractory hypoxaemia: is extracorporeal lung support the holy grail?'. Together they form a unique fingerprint.

Cite this